Biologics: Advanced Drugs that Deserve an Advanced Delivery Technology

Compared to conventional pharmaceutical drugs, biologics feature robust therapeutic efficacy, high selectivity, and limited side effects. However, there are marked limitations for the delivery of biologic drugs… Read more

A Letter From the CEO

Today we announced a groundbreaking partnership with Takeda. This is a significant milestone for Portal as it begins to validate our business model. I am thrilled about this achievement and would like to thank the whole team that has worked tirelessly to make this happen… Read more

Planning Your Feasibility Study in Three Easy Steps

Portal’s Needle-Free Drug Delivery System is now available for clinical testing, human factor evaluation, and commercial planning. For more information, click here.

The End of Needles: A Personal Win for Patients

Patients with chronic conditions who must receive frequent, sometimes even daily, injections are all too familiar with the sting and the inherent anxiety of handling needles. Click here to read about how Portal’s innovative needle-free platform is changing the paradigm of care.

Pages of the Portal Instruments website may contain links to third party websites that are not under the control of Portal Instruments. Portal Instruments is not responsible for the content of any such site and the inclusion of these links does not imply the endorsement of the content of the linked site by Portal Instruments.